VINCRISTINE SULFATE

VINCRISTINE SULFATE was reported 29521 times

VINCRISTINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 92 0.4868
1 PICORNAVIRUS INFECTION 18 0.4186
2 LYMPHOID TISSUE HYPOPLASIA 61 0.3987
3 THYMUS HYPOPLASIA 66 0.3793
4 FOLLICULAR LYMPHOMA RECURRENT 28 0.3500
5 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 17 0.2881
6 CYSTITIS BACTERIAL 71 0.2101
7 NOROVIRUS TEST POSITIVE 67 0.2062
8 BACILLUS TEST POSITIVE 19 0.1919
9 ENTEROVIRUS TEST POSITIVE 33 0.1897
10 SECONDARY IMMUNODEFICIENCY 214 0.1761
11 MYCOBACTERIUM CHELONAE INFECTION 129 0.1746
12 LEUKOERYTHROBLASTOSIS 17 0.1700
13 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 142 0.1499
14 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 326 0.1477
15 ABSCESS BACTERIAL 52 0.1433
16 TREATMENT RELATED SECONDARY MALIGNANCY 28 0.1379
17 STOMATOCOCCAL INFECTION 16 0.1290
18 MANTLE CELL LYMPHOMA RECURRENT 56 0.1287
19 NEPHROBLASTOMA 15 0.1181
20 SMOOTH MUSCLE CELL NEOPLASM 49 0.1172
21 MENINGITIS TUBERCULOUS 63 0.1127
22 CENTRAL HYPOTHYROIDISM 37 0.1118
23 ADENOVIRAL HEPATITIS 26 0.1106
24 HUMAN RHINOVIRUS TEST POSITIVE 39 0.1046
25 CAECITIS 47 0.1044
26 CORONA VIRUS INFECTION 44 0.1023
27 FOLLICULAR LYMPHOMA 78 0.0886
28 ANTITHROMBIN III DECREASED 24 0.0879
29 PSEUDOMONAL SEPSIS 151 0.0861
30 PSEUDOMONAS TEST POSITIVE 69 0.0842
31 BLOOD CULTURE POSITIVE 249 0.0831
32 HAEMOFILTRATION 15 0.0789
33 LYMPHOMA TRANSFORMATION 28 0.0778
34 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 35 0.0763
35 PARAINFLUENZAE VIRUS INFECTION 116 0.0762
36 LENNOX-GASTAUT SYNDROME 17 0.0749
37 HIGH-GRADE B-CELL LYMPHOMA 14 0.0749
38 HYPOFIBRINOGENAEMIA 74 0.0746
39 CENTRAL NERVOUS SYSTEM LYMPHOMA 97 0.0703
40 ACQUIRED GENE MUTATION 92 0.0702
41 SECOND PRIMARY MALIGNANCY 577 0.0693
42 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 16 0.0690
43 BONE MARROW NECROSIS 16 0.0684
44 BLOOD FIBRINOGEN DECREASED 78 0.0683
45 FEBRILE NEUTROPENIA 4508 0.0679
46 DISSEMINATED ASPERGILLOSIS 32 0.0678
47 ENTEROBACTER INFECTION 111 0.0660
48 FEBRILE BONE MARROW APLASIA 279 0.0656
49 HUMAN HERPESVIRUS 6 INFECTION 122 0.0645
50 CYTOMEGALOVIRUS CHORIORETINITIS 124 0.0635
51 ENTEROCOCCUS TEST POSITIVE 41 0.0633
52 HEPATITIS B REACTIVATION 194 0.0611
53 PYOMYOSITIS 18 0.0608
54 MYELOID LEUKAEMIA 30 0.0599
55 ACUTE MYELOMONOCYTIC LEUKAEMIA 15 0.0595
56 LOWER RESPIRATORY TRACT INFECTION FUNGAL 23 0.0591
57 B-CELL LYMPHOMA RECURRENT 32 0.0589
58 CANDIDA TEST POSITIVE 24 0.0574
59 KLEBSIELLA TEST POSITIVE 37 0.0568
60 PSEUDOMONAL BACTERAEMIA 48 0.0562
61 VASOGENIC CEREBRAL OEDEMA 40 0.0556
62 GLIOMA 35 0.0544
63 SUPERIOR SAGITTAL SINUS THROMBOSIS 43 0.0538
64 PULMONARY VASCULAR DISORDER 25 0.0531
65 ENTEROBACTER BACTERAEMIA 16 0.0528
66 TEMPORAL LOBE EPILEPSY 23 0.0526
67 ESCHERICHIA TEST POSITIVE 63 0.0526
68 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 41 0.0524
69 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 30 0.0508
70 PNEUMOCYSTIS JIROVECI INFECTION 14 0.0505
71 FLUID REPLACEMENT 17 0.0503
72 PNEUMATOSIS INTESTINALIS 138 0.0483
73 OTOTOXICITY 88 0.0475
74 ZYGOMYCOSIS 22 0.0470
75 DIFFUSE ALVEOLAR DAMAGE 54 0.0470
76 DIFFUSE LARGE B-CELL LYMPHOMA 361 0.0468
77 NEUTROPENIC COLITIS 94 0.0454
78 CERVIX DISORDER 32 0.0444
79 VIRAEMIA 61 0.0440
80 NEOPLASM RECURRENCE 149 0.0439
81 VENOOCCLUSIVE LIVER DISEASE 217 0.0439
82 ENTEROVIRUS INFECTION 37 0.0428
83 PLASMABLASTIC LYMPHOMA 15 0.0419
84 ACUTE PROMYELOCYTIC LEUKAEMIA 43 0.0418
85 STREPTOCOCCAL BACTERAEMIA 45 0.0414
86 ENTEROCOLITIS INFECTIOUS 38 0.0412
87 SINUSITIS FUNGAL 33 0.0411
88 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 38 0.0411
89 VENOOCCLUSIVE DISEASE 100 0.0399
90 ECTHYMA 16 0.0399
91 VIRAL HAEMORRHAGIC CYSTITIS 28 0.0393
92 GLIOBLASTOMA MULTIFORME 33 0.0392
93 ACUTE HEPATITIS B 13 0.0392
94 RHINOVIRUS INFECTION 151 0.0388
95 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 100 0.0387
96 PNEUMATOSIS 17 0.0381
97 REFUSAL OF TREATMENT BY RELATIVE 17 0.0376
98 CHYLOTHORAX 27 0.0374
99 CLOSTRIDIUM TEST POSITIVE 82 0.0372
100 HEPATITIS B CORE ANTIBODY POSITIVE 14 0.0371
101 BACILLUS INFECTION 23 0.0364
102 ACUTE LYMPHOCYTIC LEUKAEMIA 103 0.0363
103 STAPHYLOCOCCUS TEST POSITIVE 74 0.0351
104 DYSPLASIA 42 0.0350
105 PLATELET TRANSFUSION 45 0.0349
106 NEUTROPENIC SEPSIS 245 0.0343
107 PERIPHERAL MOTOR NEUROPATHY 48 0.0342
108 RED BLOOD CELL TRANSFUSION 14 0.0341
109 PNEUMONIA NECROTISING 22 0.0340
110 METASTASES TO SPLEEN 14 0.0339
111 GASTROENTERITIS NOROVIRUS 45 0.0339
112 HEPATITIS B 201 0.0333
113 KLEBSIELLA BACTERAEMIA 31 0.0326
114 TRANSVERSE SINUS THROMBOSIS 17 0.0323
115 STAPHYLOCOCCAL BACTERAEMIA 139 0.0319
116 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 160 0.0314
117 APLASIA 61 0.0311
118 TUMOUR LYSIS SYNDROME 267 0.0303
119 FUNGAL SEPSIS 25 0.0301
120 CORYNEBACTERIUM INFECTION 16 0.0299
121 DEVICE RELATED THROMBOSIS 29 0.0294
122 LYMPHADENITIS 71 0.0293
123 OTITIS MEDIA ACUTE 21 0.0285
124 STRONGYLOIDIASIS 46 0.0284
125 INTUSSUSCEPTION 27 0.0283
126 CANDIDA SEPSIS 25 0.0279
127 ESCHERICHIA BACTERAEMIA 65 0.0276
128 LEUKAEMIA RECURRENT 46 0.0272
129 HYPERBILIRUBINAEMIA 277 0.0267
130 MUCOSAL INFLAMMATION 700 0.0267
131 SARS-COV-2 TEST NEGATIVE 18 0.0267
132 SYSTEMIC CANDIDA 67 0.0267
133 APLASTIC ANAEMIA 139 0.0266
134 CLOSTRIDIUM DIFFICILE COLITIS 280 0.0264
135 BACTERIAL SEPSIS 84 0.0258
136 FUSARIUM INFECTION 18 0.0257
137 SYSTEMIC MYCOSIS 30 0.0257
138 BRONCHOPULMONARY ASPERGILLOSIS 198 0.0255
139 GENE MUTATION 50 0.0252
140 URINARY TRACT INFECTION PSEUDOMONAL 15 0.0250
141 PERIPHERAL SENSORIMOTOR NEUROPATHY 31 0.0247
142 CYSTITIS NONINFECTIVE 33 0.0246
143 ACUTE MYELOID LEUKAEMIA 380 0.0244
144 OESOPHAGEAL CANDIDIASIS 96 0.0241
145 CELLULITIS ORBITAL 14 0.0240
146 KLEBSIELLA SEPSIS 27 0.0240
147 VENOUS THROMBOSIS 94 0.0239
148 CYTOMEGALOVIRUS VIRAEMIA 106 0.0238
149 INFECTION IN AN IMMUNOCOMPROMISED HOST 17 0.0237
150 MYELODYSPLASTIC SYNDROME 341 0.0236
151 ABDOMINAL COMPARTMENT SYNDROME 15 0.0235
152 LEUKOENCEPHALOPATHY 87 0.0233
153 B-CELL TYPE ACUTE LEUKAEMIA 17 0.0232
154 CEREBRAL VENOUS THROMBOSIS 42 0.0231
155 CATHETER RELATED INFECTION 23 0.0227
156 MYELOSUPPRESSION 795 0.0221
157 ANAL ULCER 18 0.0220
158 HYPERTRIGLYCERIDAEMIA 129 0.0220
159 STEROID DIABETES 33 0.0220
160 BONE MARROW TOXICITY 26 0.0219
161 PANCREATIC PSEUDOCYST 17 0.0219
162 CULTURE POSITIVE 18 0.0215
163 HERPES SIMPLEX 138 0.0212
164 FUNGAEMIA 33 0.0210
165 ENTEROCOCCAL BACTERAEMIA 22 0.0208
166 CULTURE URINE POSITIVE 29 0.0206
167 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 197 0.0206
168 MUCORMYCOSIS 52 0.0200
169 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 14 0.0199
170 BACTERIAL INFECTION 370 0.0198
171 ASPERGILLUS INFECTION 130 0.0198
172 HAEMATOTOXICITY 188 0.0198
173 AUTONOMIC NEUROPATHY 20 0.0197
174 PNEUMOCYSTIS JIROVECI PNEUMONIA 44 0.0197
175 EPSTEIN-BARR VIRUS INFECTION 123 0.0197
176 CORONAVIRUS TEST POSITIVE 20 0.0194
177 CONTINUOUS HAEMODIAFILTRATION 19 0.0194
178 ESCHERICHIA SEPSIS 56 0.0193
179 SEPTIC EMBOLUS 16 0.0192
180 HYPERLEUKOCYTOSIS 17 0.0192
181 BILIRUBIN CONJUGATED INCREASED 44 0.0188
182 PROCALCITONIN INCREASED 22 0.0187
183 NEOPLASM PROGRESSION 650 0.0187
184 INTRACRANIAL VENOUS SINUS THROMBOSIS 20 0.0187
185 ENTERITIS 119 0.0186
186 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 153 0.0185
187 GASTROINTESTINAL NECROSIS 54 0.0185
188 CARDIOTOXICITY 165 0.0185
189 INFECTION REACTIVATION 21 0.0183
190 HISTIOCYTOSIS HAEMATOPHAGIC 54 0.0182
191 B-CELL LYMPHOMA 61 0.0179
192 PUPIL FIXED 31 0.0179
193 KLEBSIELLA INFECTION 90 0.0178
194 BACTERAEMIA 209 0.0176
195 ILEUS PARALYTIC 78 0.0175
196 BONE MARROW FAILURE 352 0.0173
197 STEM CELL TRANSPLANT 43 0.0172
198 PANCYTOPENIA 947 0.0169
199 ABDOMINAL NEOPLASM 15 0.0168
200 LUNG CONSOLIDATION 47 0.0168
201 HYPOGAMMAGLOBULINAEMIA 110 0.0167
202 NEUTROPENIC INFECTION 16 0.0167
203 SUBCLAVIAN VEIN THROMBOSIS 19 0.0167
204 PACKED RED BLOOD CELL TRANSFUSION 22 0.0166
205 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 29 0.0164
206 ENTEROCOCCAL INFECTION 78 0.0161
207 TUMOUR NECROSIS 17 0.0161
208 VENTRICULAR DYSFUNCTION 41 0.0158
209 GALLBLADDER ENLARGEMENT 17 0.0158
210 MYELOPATHY 30 0.0158
211 NEUTROPHIL COUNT DECREASED 643 0.0158
212 INTRACARDIAC THROMBUS 48 0.0156
213 GRANULOCYTE COUNT DECREASED 29 0.0156
214 VOCAL CORD PARALYSIS 28 0.0156
215 CYTOPENIA 190 0.0155
216 PNEUMOCYSTIS JIROVECII PNEUMONIA 155 0.0154
217 ASPERGILLOSIS 20 0.0153
218 SEPTIC SHOCK 666 0.0153
219 CYTOMEGALOVIRUS TEST POSITIVE 27 0.0151
220 QUADRIPARESIS 25 0.0151
221 BLOOD LACTATE DEHYDROGENASE INCREASED 236 0.0149
222 HEPATOSPLENOMEGALY 38 0.0148
223 DRUG CLEARANCE DECREASED 19 0.0145
224 NON-HODGKIN'S LYMPHOMA 19 0.0145
225 STAPHYLOCOCCAL SEPSIS 71 0.0144
226 BACTERIAL TEST POSITIVE 32 0.0143
227 INTERSTITIAL LUNG DISEASE 684 0.0141
228 INTENSIVE CARE 20 0.0141
229 JUGULAR VEIN THROMBOSIS 25 0.0140
230 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 71 0.0140
231 MANTLE CELL LYMPHOMA 21 0.0138
232 DISSEMINATED INTRAVASCULAR COAGULATION 194 0.0138
233 ACINETOBACTER INFECTION 15 0.0137
234 CYSTITIS HAEMORRHAGIC 55 0.0136
235 PSEUDOMONAS INFECTION 117 0.0136
236 QUADRIPLEGIA 28 0.0136
237 CRYPTOCOCCOSIS 22 0.0135
238 ATELECTASIS 130 0.0134
239 HAEMOLYTIC URAEMIC SYNDROME 31 0.0134
240 HEPATOMEGALY 131 0.0133
241 PNEUMOMEDIASTINUM 24 0.0133
242 PULSE ABSENT 63 0.0132
243 CARDIAC VENTRICULAR THROMBOSIS 17 0.0132
244 JC VIRUS INFECTION 21 0.0131
245 BLOOD LACTIC ACID INCREASED 69 0.0131
246 PNEUMOPERITONEUM 24 0.0130
247 CANDIDIASIS 52 0.0130
248 PNEUMONIA FUNGAL 51 0.0129
249 NEUTROPENIA 1755 0.0129
250 PNEUMONIA CYTOMEGALOVIRAL 25 0.0129
251 MULTIPLE ORGAN DYSFUNCTION SYNDROME 359 0.0127
252 LYMPHADENOPATHY MEDIASTINAL 24 0.0125
253 PERIPHERAL SENSORY NEUROPATHY 73 0.0125
254 CYTOMEGALOVIRUS INFECTION REACTIVATION 55 0.0124
255 ACUTE HEPATIC FAILURE 170 0.0124
256 ADENOVIRUS INFECTION 36 0.0124
257 COMPUTERISED TOMOGRAM ABNORMAL 28 0.0124
258 LYMPHOCYTOSIS 26 0.0121
259 BRAIN HERNIATION 36 0.0120
260 ESCHERICHIA INFECTION 99 0.0120
261 GASTROINTESTINAL WALL THICKENING 18 0.0120
262 NEUROTOXICITY 209 0.0119
263 NECROTISING COLITIS 15 0.0118
264 PNEUMOCYSTIS JIROVECII INFECTION 14 0.0117
265 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 120 0.0117
266 CEREBRAL ISCHAEMIA 60 0.0116
267 COAGULOPATHY 193 0.0116
268 ENCEPHALITIS 80 0.0116
269 LUNG INFILTRATION 102 0.0115
270 ENTEROCOLITIS 65 0.0112
271 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 14 0.0112
272 AREFLEXIA 30 0.0112
273 CAPILLARY LEAK SYNDROME 23 0.0111
274 STENOTROPHOMONAS INFECTION 15 0.0111
275 HYPOALBUMINAEMIA 86 0.0110
276 SOFT TISSUE INFECTION 20 0.0109
277 BLOOD BILIRUBIN INCREASED 295 0.0109
278 TACHYPNOEA 148 0.0109
279 NEUROLOGICAL SYMPTOM 62 0.0108
280 VACCINATION FAILURE 18 0.0108
281 NEUROLOGICAL DECOMPENSATION 25 0.0108
282 LOBAR PNEUMONIA 20 0.0108
283 TONIC CLONIC MOVEMENTS 14 0.0108
284 ILEUS 133 0.0107
285 SUSPECTED OFF LABEL USE 48 0.0106
286 VARICELLA ZOSTER VIRUS INFECTION 22 0.0106
287 HEPATIC CYTOLYSIS 134 0.0105
288 INTESTINAL DILATATION 14 0.0105
289 CHEST X-RAY ABNORMAL 32 0.0104
290 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 15 0.0103
291 PULSELESS ELECTRICAL ACTIVITY 43 0.0103
292 LUNG OPACITY 27 0.0102
293 LEFT VENTRICULAR DYSFUNCTION 68 0.0101
294 ENTEROCOLITIS HAEMORRHAGIC 15 0.0101
295 HEPATITIS E 16 0.0101
296 LYMPHOPENIA 142 0.0100
297 SEPSIS 1110 0.0099
298 BLOOD PH DECREASED 17 0.0099
299 PULMONARY HAEMORRHAGE 77 0.0098
300 CYTOMEGALOVIRUS INFECTION 162 0.0097
301 MENINGITIS CRYPTOCOCCAL 17 0.0097
302 ACIDOSIS 74 0.0097
303 RESPIRATORY DISTRESS 265 0.0096
304 SMALL INTESTINAL PERFORATION 18 0.0096
305 LIPASE INCREASED 73 0.0095
306 BLOOD PHOSPHORUS INCREASED 26 0.0095
307 BONE MARROW DISORDER 28 0.0093
308 NEUTROPHIL COUNT ABNORMAL 26 0.0092
309 ESCHERICHIA URINARY TRACT INFECTION 39 0.0092
310 MULTI-ORGAN DISORDER 18 0.0091
311 CYTOKINE RELEASE SYNDROME 180 0.0090
312 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 53 0.0089
313 ASCITES 263 0.0089
314 HAEMODYNAMIC INSTABILITY 68 0.0089
315 CLOSTRIDIAL INFECTION 30 0.0089
316 CEREBRAL THROMBOSIS 25 0.0088
317 HEPATIC FAILURE 266 0.0088
318 ACUTE RESPIRATORY DISTRESS SYNDROME 156 0.0088
319 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 66 0.0088
320 BRAIN DEATH 27 0.0087
321 FIBRIN D DIMER INCREASED 31 0.0087
322 PROTHROMBIN TIME PROLONGED 52 0.0087
323 HAEMOLYSIS 67 0.0087
324 THERAPY PARTIAL RESPONDER 135 0.0086
325 DISEASE PROGRESSION 1012 0.0085
326 HYPERPYREXIA 36 0.0085
327 CATHETER SITE HAEMORRHAGE 21 0.0084
328 BRAIN OEDEMA 106 0.0084
329 LEUKOPENIA 419 0.0084
330 METASTASES TO MENINGES 19 0.0083
331 POLYNEUROPATHY 100 0.0083
332 NECROTISING FASCIITIS 29 0.0082
333 CHRONIC LYMPHOCYTIC LEUKAEMIA 39 0.0082
334 GAZE PALSY 14 0.0082
335 ENCEPHALOPATHY 201 0.0082
336 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 19 0.0081
337 EJECTION FRACTION DECREASED 126 0.0081
338 LYMPH NODE PAIN 15 0.0081
339 AGRANULOCYTOSIS 149 0.0080
340 HYPOPHAGIA 204 0.0080
341 HEPATIC NECROSIS 30 0.0080
342 RED CELL DISTRIBUTION WIDTH INCREASED 33 0.0079
343 HYPERTRANSAMINASAEMIA 55 0.0079
344 INTRACRANIAL PRESSURE INCREASED 44 0.0079
345 PNEUMONIA VIRAL 25 0.0078
346 ABDOMINAL MASS 21 0.0078
347 PANCREATITIS NECROTISING 18 0.0078
348 COLITIS 296 0.0078
349 THROMBOCYTOPENIA 866 0.0077
350 CHRONIC SINUSITIS 29 0.0077
351 BICYTOPENIA 15 0.0076
352 PNEUMONIA KLEBSIELLA 14 0.0076
353 HYPOXIA 267 0.0076
354 CELL DEATH 15 0.0076
355 ELECTROLYTE IMBALANCE 87 0.0075
356 VIRAL INFECTION 249 0.0075
357 POTENTIATING DRUG INTERACTION 25 0.0074
358 TRANSFUSION 78 0.0074
359 HYPERPHOSPHATAEMIA 16 0.0074
360 CANDIDA INFECTION 125 0.0074
361 HYPERAMMONAEMIA 37 0.0074
362 DEVICE RELATED INFECTION 112 0.0073
363 RESPIRATORY FAILURE 528 0.0072
364 GRAFT VERSUS HOST DISEASE 52 0.0072
365 HEPATIC LESION 31 0.0072
366 HEPATOTOXICITY 159 0.0071
367 PLEURAL EFFUSION 434 0.0071
368 COVID-19 PNEUMONIA 84 0.0071
369 BRAIN ABSCESS 18 0.0071
370 HEPATIC STEATOSIS 132 0.0071
371 GASTROINTESTINAL TOXICITY 34 0.0071
372 APNOEA 55 0.0071
373 ORAL INTAKE REDUCED 17 0.0070
374 HAEMORRHAGE INTRACRANIAL 105 0.0070
375 CATHETER SITE ERYTHEMA 15 0.0070
376 HEPATIC FIBROSIS 24 0.0070
377 OTITIS MEDIA 23 0.0070
378 LYMPHOCYTE COUNT DECREASED 123 0.0070
379 NEUROPATHY PERIPHERAL 658 0.0069
380 WHITE BLOOD CELL COUNT DECREASED 747 0.0069
381 MONOCYTE COUNT INCREASED 25 0.0069
382 INTESTINAL PERFORATION 77 0.0069
383 VENOUS THROMBOSIS LIMB 14 0.0068
384 LYMPHADENOPATHY 240 0.0068
385 CARDIOMYOPATHY 99 0.0067
386 HYPERGLYCAEMIA 243 0.0067
387 MENTAL STATUS CHANGES 185 0.0067
388 FUNGAL INFECTION 220 0.0066
389 LYMPHOMA 101 0.0065
390 ODYNOPHAGIA 39 0.0065
391 AZOTAEMIA 26 0.0065
392 AMMONIA INCREASED 33 0.0065
393 HAEMODIALYSIS 54 0.0064
394 PNEUMONITIS 174 0.0064
395 PULMONARY INFARCTION 15 0.0063
396 ELECTROENCEPHALOGRAM ABNORMAL 20 0.0063
397 STOMATITIS 384 0.0063
398 METABOLIC ENCEPHALOPATHY 19 0.0063
399 GRANULOCYTOPENIA 36 0.0063
400 STREPTOCOCCAL INFECTION 35 0.0063
401 OLIGURIA 39 0.0063
402 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 24 0.0063
403 MIGRAINE WITH AURA 17 0.0063
404 PLATELET COUNT DECREASED 666 0.0062
405 CONGESTIVE CARDIOMYOPATHY 26 0.0062
406 BK VIRUS INFECTION 21 0.0062
407 ALANINE AMINOTRANSFERASE INCREASED 381 0.0062
408 PANCREATITIS ACUTE 137 0.0061
409 HYDROCEPHALUS 33 0.0061
410 CHOLESTASIS 116 0.0060
411 ABDOMINAL TENDERNESS 30 0.0060
412 TACHYCARDIA 536 0.0060
413 MULTI-ORGAN FAILURE 104 0.0060
414 HEPATOCELLULAR INJURY 85 0.0060
415 ACUTE RESPIRATORY FAILURE 115 0.0060
416 AMYLASE INCREASED 22 0.0060
417 JAUNDICE CHOLESTATIC 21 0.0059
418 TOXIC ENCEPHALOPATHY 30 0.0059
419 VENTRICULAR HYPOKINESIA 19 0.0059
420 FLUID OVERLOAD 86 0.0059
421 HEPATIC ENCEPHALOPATHY 55 0.0059
422 VARICELLA 14 0.0059
423 SINUS TACHYCARDIA 83 0.0058
424 STAPHYLOCOCCAL INFECTION 192 0.0058
425 CATHETER SITE INFECTION 22 0.0058
426 BLOOD ALBUMIN DECREASED 46 0.0058
427 PLEURITIC PAIN 16 0.0058
428 BLOOD CREATININE DECREASED 18 0.0057
429 URINE OUTPUT DECREASED 50 0.0057
430 FACIAL PARALYSIS 48 0.0056
431 PYREXIA 1945 0.0056
432 PERSECUTORY DELUSION 14 0.0056
433 WHITE BLOOD CELL DISORDER 15 0.0056
434 CORONAVIRUS INFECTION 37 0.0056
435 MYOSITIS 50 0.0056
436 NECROSIS 31 0.0056
437 APPENDICITIS 52 0.0056
438 DIASTOLIC DYSFUNCTION 17 0.0055
439 BODY TEMPERATURE INCREASED 110 0.0054
440 MENINGITIS 36 0.0054
441 HERPES VIRUS INFECTION 31 0.0054
442 ORAL HERPES 105 0.0054
443 SPLENOMEGALY 63 0.0054
444 NEPHROPATHY TOXIC 60 0.0053
445 ACUTE PULMONARY OEDEMA 30 0.0053
446 SUBDURAL HAEMATOMA 76 0.0053
447 TRANSAMINASES INCREASED 118 0.0053
448 RESPIRATORY SYMPTOM 15 0.0053
449 OESOPHAGEAL STENOSIS 15 0.0053
450 IMMUNE THROMBOCYTOPENIA 24 0.0052
451 END STAGE RENAL DISEASE 95 0.0052
452 DIALYSIS 73 0.0051
453 ASPARTATE AMINOTRANSFERASE INCREASED 271 0.0051
454 MALNUTRITION 57 0.0051
455 CLOSTRIDIUM DIFFICILE INFECTION 111 0.0051
456 PARTIAL SEIZURES 26 0.0050
457 HYPOVOLAEMIA 29 0.0050
458 RESPIRATORY RATE INCREASED 44 0.0050
459 ABSCESS LIMB 21 0.0049
460 NO THERAPEUTIC RESPONSE 60 0.0049
461 TUMOUR HAEMORRHAGE 14 0.0049
462 LARGE INTESTINE PERFORATION 34 0.0049
463 UNRESPONSIVE TO STIMULI 126 0.0049
464 HYPOPHOSPHATAEMIA 36 0.0049
465 PORTAL HYPERTENSION 15 0.0049
466 ORAL CANDIDIASIS 64 0.0049
467 BLOOD URIC ACID INCREASED 28 0.0048
468 DRUG TOXICITY 66 0.0048
469 HYDRONEPHROSIS 36 0.0048
470 PLATELET COUNT ABNORMAL 29 0.0048
471 BRAIN INJURY 48 0.0048
472 GROWTH RETARDATION 14 0.0048
473 HYPERVOLAEMIA 23 0.0046
474 LIVER ABSCESS 15 0.0046
475 HYPERURICAEMIA 19 0.0046
476 THROMBOTIC MICROANGIOPATHY 45 0.0046
477 HEPATITIS ACUTE 30 0.0046
478 PATHOGEN RESISTANCE 42 0.0046
479 DRUG RESISTANCE 118 0.0046
480 DIVERTICULUM INTESTINAL 20 0.0046
481 UROSEPSIS 42 0.0045
482 FACIAL PARESIS 16 0.0045
483 PURPURA 40 0.0045
484 PROCTALGIA 29 0.0045
485 PETECHIAE 47 0.0045
486 HAEMOGLOBIN DECREASED 462 0.0045
487 HEART RATE ABNORMAL 25 0.0045
488 RESPIRATORY SYNCYTIAL VIRUS INFECTION 39 0.0045
489 ORGANISING PNEUMONIA 22 0.0044
490 HEMIPARESIS 75 0.0044
491 PANCREATITIS 234 0.0044
492 ANAEMIA 841 0.0044
493 HYPOTENSION 882 0.0044
494 HYPONATRAEMIA 247 0.0044
495 GENERALISED OEDEMA 54 0.0044
496 IMMUNE-MEDIATED ENTEROCOLITIS 16 0.0043
497 RESPIRATORY ACIDOSIS 17 0.0043
498 PNEUMOTHORAX 68 0.0043
499 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
500 PROTEIN TOTAL DECREASED 16 0.0042
501 LEUKAEMIA 40 0.0042
502 SMALL INTESTINAL OBSTRUCTION 52 0.0042
503 CARDIAC FAILURE CHRONIC 18 0.0042
504 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
505 PAPILLOEDEMA 19 0.0042
506 CHOLECYSTITIS 50 0.0042
507 PERICARDIAL EFFUSION 97 0.0042
508 ARTHRITIS BACTERIAL 17 0.0041
509 TROPONIN INCREASED 31 0.0041
510 HEPATIC FUNCTION ABNORMAL 152 0.0041
511 LEFT VENTRICULAR FAILURE 14 0.0041
512 HYPOKALAEMIA 187 0.0040
513 PNEUMONIA BACTERIAL 37 0.0040
514 ATRIAL FLUTTER 32 0.0040
515 FLUID INTAKE REDUCED 20 0.0040
516 POOR PERIPHERAL CIRCULATION 17 0.0040
517 SERUM FERRITIN INCREASED 21 0.0040
518 VASCULAR DEVICE INFECTION 18 0.0040
519 METABOLIC DISORDER 23 0.0040
520 BLOOD MAGNESIUM DECREASED 34 0.0039
521 CHRONIC MYELOID LEUKAEMIA 18 0.0039
522 INFECTION 561 0.0039
523 MASS 54 0.0039
524 CELLULITIS 194 0.0038
525 CARDIOPULMONARY FAILURE 15 0.0038
526 ABDOMINAL ABSCESS 17 0.0038
527 GENERALISED TONIC-CLONIC SEIZURE 63 0.0038
528 LUNG INFECTION 59 0.0038
529 EYE MOVEMENT DISORDER 26 0.0038
530 ORAL PAIN 85 0.0038
531 SARCOIDOSIS 18 0.0038
532 MALIGNANT NEOPLASM PROGRESSION 381 0.0037
533 ISCHAEMIA 17 0.0037
534 THERAPY NON-RESPONDER 166 0.0037
535 OCULAR ICTERUS 16 0.0037
536 RECURRENT CANCER 15 0.0037
537 MOUTH ULCERATION 77 0.0037
538 OESOPHAGEAL ULCER 14 0.0036
539 NEUTROPHIL COUNT INCREASED 37 0.0036
540 HEPATITIS 92 0.0036
541 NYSTAGMUS 19 0.0036
542 HAEMOGLOBIN ABNORMAL 23 0.0036
543 CARDIO-RESPIRATORY ARREST 149 0.0036
544 JAUNDICE 95 0.0035
545 REFUSAL OF TREATMENT BY PATIENT 23 0.0035
546 SHOCK 81 0.0035
547 RASH VESICULAR 17 0.0035
548 GUILLAIN-BARRE SYNDROME 17 0.0035
549 IMMUNOSUPPRESSION 31 0.0035
550 LUNG NEOPLASM 15 0.0035
551 ENDOCARDITIS 18 0.0035
552 BLOOD TRIGLYCERIDES INCREASED 62 0.0035
553 CACHEXIA 18 0.0035
554 PULMONARY MASS 52 0.0035
555 FAECALOMA 19 0.0035
556 PALLOR 94 0.0035
557 GASTROINTESTINAL INFLAMMATION 27 0.0034
558 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
559 GAMMA-GLUTAMYLTRANSFERASE INCREASED 76 0.0034
560 PERFORMANCE STATUS DECREASED 16 0.0034
561 IMMUNODEFICIENCY 51 0.0034
562 HYPERCALCAEMIA 42 0.0034
563 PULMONARY TOXICITY 24 0.0034
564 HYPOCALCAEMIA 64 0.0034
565 HAEMATOCRIT DECREASED 67 0.0034
566 MATERNAL EXPOSURE BEFORE PREGNANCY 23 0.0034
567 VIRAL UPPER RESPIRATORY TRACT INFECTION 16 0.0034
568 FEAR OF INJECTION 24 0.0034
569 OESOPHAGITIS 36 0.0033
570 WHITE BLOOD CELL COUNT ABNORMAL 21 0.0033
571 ABDOMINAL PAIN 763 0.0033
572 FAILURE TO THRIVE 17 0.0033
573 MOUTH HAEMORRHAGE 24 0.0033
574 STRESS CARDIOMYOPATHY 19 0.0033
575 METABOLIC ACIDOSIS 104 0.0032
576 SUBARACHNOID HAEMORRHAGE 33 0.0032
577 DEEP VEIN THROMBOSIS 209 0.0032
578 ADRENAL INSUFFICIENCY 39 0.0032
579 RESPIRATORY DISORDER 96 0.0032
580 INFUSION RELATED REACTION 212 0.0032
581 CEREBRAL INFARCTION 78 0.0032
582 ORTHOSTATIC HYPOTENSION 55 0.0032
583 HEPATITIS CHOLESTATIC 19 0.0032
584 ACUTE CORONARY SYNDROME 26 0.0031
585 SARS-COV-2 TEST POSITIVE 41 0.0031
586 ACUTE KIDNEY INJURY 474 0.0031
587 OXYGEN SATURATION DECREASED 172 0.0031
588 GASTRIC ULCER 58 0.0030
589 BLOOD UREA INCREASED 51 0.0030
590 CARDIAC ARREST 251 0.0030
591 DYSGRAPHIA 20 0.0030
592 SKIN INFECTION 34 0.0030
593 SUPRAVENTRICULAR TACHYCARDIA 29 0.0030
594 EMBOLISM 25 0.0030
595 PULMONARY OEDEMA 134 0.0030
596 PERONEAL NERVE PALSY 17 0.0030
597 VENTRICULAR FIBRILLATION 33 0.0030
598 ANAL ABSCESS 16 0.0030
599 BLOOD CALCIUM DECREASED 33 0.0029
600 ANGINA UNSTABLE 19 0.0029
601 OSTEONECROSIS 96 0.0029
602 CARDIAC FAILURE 234 0.0029
603 VENTRICULAR TACHYCARDIA 48 0.0029
604 CHOLANGITIS 18 0.0029
605 PNEUMONIA 936 0.0029
606 HAEMATEMESIS 73 0.0029
607 SEIZURE 331 0.0029
608 ORAL DISORDER 21 0.0029
609 HYPOTHERMIA 29 0.0029
610 PRODUCT USE IN UNAPPROVED INDICATION 707 0.0028
611 LIVER INJURY 70 0.0028
612 MOTOR DYSFUNCTION 29 0.0028
613 PULMONARY ARTERIAL HYPERTENSION 41 0.0028
614 CHOLECYSTITIS ACUTE 16 0.0028
615 GRAND MAL CONVULSION 26 0.0028
616 BLOOD SODIUM DECREASED 53 0.0028
617 HYPERNATRAEMIA 14 0.0028
618 METASTASIS 20 0.0028
619 ANAL FISSURE 15 0.0028
620 HAEMOLYTIC ANAEMIA 25 0.0028
621 ANURIA 24 0.0028
622 NERVOUS SYSTEM DISORDER 87 0.0028
623 NEOPLASM 32 0.0028
624 MYOPATHY 24 0.0028
625 C-REACTIVE PROTEIN INCREASED 101 0.0028
626 DISEASE RECURRENCE 131 0.0028
627 STATUS EPILEPTICUS 31 0.0027
628 PULMONARY EMBOLISM 259 0.0027
629 SHOCK HAEMORRHAGIC 22 0.0027
630 TENDERNESS 28 0.0027
631 RENAL FAILURE ACUTE 114 0.0027
632 POST PROCEDURAL HAEMORRHAGE 31 0.0027
633 EYELID PTOSIS 27 0.0027
634 DEAFNESS 69 0.0026
635 HAEMATURIA 90 0.0026
636 LETHARGY 151 0.0026
637 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
638 BRADYCARDIA 138 0.0026
639 CEREBRAL HAEMORRHAGE 93 0.0026
640 LEUKOCYTOSIS 47 0.0026
641 FLANK PAIN 24 0.0026
642 INTESTINAL ISCHAEMIA 14 0.0025
643 GASTRIC ULCER HAEMORRHAGE 14 0.0025
644 CHILLS 295 0.0025
645 HYPOMAGNESAEMIA 35 0.0025
646 BLOOD PRESSURE DECREASED 166 0.0025
647 DERMATITIS BULLOUS 18 0.0025
648 DRUG-INDUCED LIVER INJURY 78 0.0025
649 DIARRHOEA HAEMORRHAGIC 23 0.0025
650 APHASIA 74 0.0024
651 HICCUPS 20 0.0024
652 RASH MACULO-PAPULAR 54 0.0024
653 BLOOD CREATININE INCREASED 157 0.0024
654 DEHYDRATION 320 0.0024
655 BONE PAIN 139 0.0024
656 METASTASES TO LYMPH NODES 16 0.0024
657 GENERAL PHYSICAL HEALTH DETERIORATION 274 0.0024
658 ATAXIA 28 0.0024
659 CARDIOMEGALY 29 0.0024
660 METASTASES TO LUNG 27 0.0023
661 ECCHYMOSIS 16 0.0023
662 PARALYSIS 33 0.0023
663 DEPRESSED LEVEL OF CONSCIOUSNESS 91 0.0023
664 CARDIOGENIC SHOCK 33 0.0023
665 CEREBRAL DISORDER 17 0.0023
666 DISORIENTATION 91 0.0023
667 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
668 GROIN PAIN 20 0.0023
669 CYSTITIS 72 0.0023
670 CARDIAC FAILURE ACUTE 15 0.0022
671 HYPERTHERMIA 17 0.0022
672 CYANOSIS 35 0.0022
673 BLOOD TEST ABNORMAL 31 0.0022
674 HYPOTONIA 22 0.0022
675 VOMITING 1028 0.0022
676 MELAENA 48 0.0022
677 RESPIRATION ABNORMAL 15 0.0022
678 PERITONITIS 45 0.0022
679 INTENTIONAL PRODUCT USE ISSUE 190 0.0022
680 GASTROINTESTINAL HAEMORRHAGE 180 0.0022
681 TOXICITY TO VARIOUS AGENTS 363 0.0022
682 CHOLELITHIASIS 70 0.0021
683 LACTIC ACIDOSIS 69 0.0021
684 GASTROENTERITIS 31 0.0021
685 ACUTE MYOCARDIAL INFARCTION 62 0.0021
686 PREMATURE BABY 63 0.0021
687 TOXIC SKIN ERUPTION 21 0.0021
688 DRUG LEVEL INCREASED 34 0.0021
689 RENAL TUBULAR NECROSIS 20 0.0020
690 MITRAL VALVE INCOMPETENCE 23 0.0020
691 LOWER GASTROINTESTINAL HAEMORRHAGE 15 0.0020
692 RED BLOOD CELL COUNT DECREASED 58 0.0020
693 RENAL FAILURE 269 0.0020
694 DYSARTHRIA 76 0.0020
695 SKIN LESION 55 0.0020
696 DELIRIUM 69 0.0020
697 DUODENAL ULCER 14 0.0020
698 OFF LABEL USE 1730 0.0020
699 BLOOD ALKALINE PHOSPHATASE INCREASED 49 0.0020
700 DIVERTICULUM 14 0.0020
701 CONSTIPATION 429 0.0020
702 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
703 PAIN IN JAW 55 0.0019
704 ATRIAL FIBRILLATION 189 0.0019
705 METASTASES TO CENTRAL NERVOUS SYSTEM 25 0.0019
706 CIRCULATORY COLLAPSE 33 0.0019
707 DYSURIA 71 0.0019
708 PARANOIA 33 0.0019
709 PRODUCTIVE COUGH 91 0.0019
710 TRICUSPID VALVE INCOMPETENCE 15 0.0019
711 DYSPNOEA EXERTIONAL 71 0.0019
712 LIVER DISORDER 83 0.0019
713 CONVULSION 107 0.0019
714 HAEMOPTYSIS 52 0.0019
715 BLOOD POTASSIUM DECREASED 56 0.0019
716 WHITE BLOOD CELL COUNT INCREASED 71 0.0018
717 RENAL IMPAIRMENT 154 0.0018
718 PROCEDURAL COMPLICATION 14 0.0018
719 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
720 MUSCLE TWITCHING 42 0.0018
721 ABSCESS 29 0.0018
722 HEPATIC ENZYME INCREASED 123 0.0018
723 HEMIPLEGIA 15 0.0018
724 THROMBOSIS 145 0.0018
725 HERPES ZOSTER 103 0.0018
726 PULMONARY FIBROSIS 34 0.0018
727 COVID-19 310 0.0018
728 UPPER RESPIRATORY TRACT INFECTION 81 0.0018
729 PULMONARY CONGESTION 23 0.0017
730 HYPERKALAEMIA 61 0.0017
731 DYSPHAGIA 158 0.0017
732 ABDOMINAL DISTENSION 173 0.0017
733 PHOTOPHOBIA 31 0.0016
734 NIGHT SWEATS 53 0.0016
735 EPISTAXIS 123 0.0016
736 ASPIRATION 18 0.0016
737 SKIN ULCER 42 0.0016
738 PYELONEPHRITIS 14 0.0016
739 NEURALGIA 38 0.0016
740 MUSCULOSKELETAL CHEST PAIN 24 0.0015
741 EPILEPSY 47 0.0015
742 LIVER FUNCTION TEST INCREASED 33 0.0015
743 OROPHARYNGEAL PAIN 142 0.0015
744 COMA 73 0.0015
745 BODY TEMPERATURE DECREASED 15 0.0015
746 PRESYNCOPE 37 0.0015
747 GASTRITIS 40 0.0015
748 HYPOTHYROIDISM 48 0.0015
749 SYNCOPE 150 0.0015
750 FULL BLOOD COUNT DECREASED 30 0.0015
751 SQUAMOUS CELL CARCINOMA 14 0.0015
752 GASTRIC HAEMORRHAGE 17 0.0015
753 URINARY RETENTION 49 0.0015
754 PERIPHERAL COLDNESS 20 0.0015
755 DECREASED APPETITE 337 0.0014
756 ULCER 23 0.0014
757 VENTRICULAR EXTRASYSTOLES 15 0.0014
758 ASTHENIA 543 0.0014
759 MUSCULAR WEAKNESS 164 0.0014
760 OSTEOMYELITIS 26 0.0014
761 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
762 HYPERLIPIDAEMIA 17 0.0014
763 RECTAL HAEMORRHAGE 61 0.0014
764 SUDDEN DEATH 15 0.0014
765 LUNG DISORDER 69 0.0014
766 MYOCARDIAL ISCHAEMIA 16 0.0014
767 GALLBLADDER DISORDER 25 0.0014
768 ANAPHYLACTIC REACTION 77 0.0014
769 PULMONARY HYPERTENSION 29 0.0014
770 BLOOD COUNT ABNORMAL 21 0.0014
771 PHARYNGITIS 17 0.0014
772 EOSINOPHILIA 24 0.0014
773 HAEMATOMA 35 0.0013
774 OEDEMA 73 0.0013
775 MATERNAL EXPOSURE DURING PREGNANCY 119 0.0013
776 HAEMORRHOIDS 26 0.0013
777 RASH ERYTHEMATOUS 63 0.0013
778 DRUG INTERACTION 207 0.0013
779 CONFUSIONAL STATE 210 0.0013
780 HEART RATE INCREASED 127 0.0013
781 HYPERTENSION 265 0.0012
782 COUGH 350 0.0012
783 EAR PAIN 24 0.0012
784 NAUSEA 973 0.0012
785 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
786 RHINORRHOEA 78 0.0012
787 DIARRHOEA 778 0.0012
788 LIVER FUNCTION TEST ABNORMAL 35 0.0012
789 SPINAL PAIN 14 0.0012
790 FACE OEDEMA 20 0.0012
791 AGITATION 87 0.0012
792 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65 0.0012
793 FEEDING DISORDER 24 0.0012
794 CONDITION AGGRAVATED 358 0.0012
795 GASTROINTESTINAL DISORDER 105 0.0012
796 BLOOD POTASSIUM INCREASED 19 0.0012
797 THYROID CANCER 14 0.0012
798 CARDIAC DISORDER 108 0.0012
799 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 29 0.0011
800 RESPIRATORY ARREST 31 0.0011
801 LUNG NEOPLASM MALIGNANT 46 0.0011
802 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
803 ABDOMINAL PAIN LOWER 28 0.0011
804 HYPOGLYCAEMIA 53 0.0011
805 BASAL CELL CARCINOMA 17 0.0011
806 EATING DISORDER 23 0.0011
807 DIPLOPIA 28 0.0011
808 RESPIRATORY TRACT INFECTION 28 0.0011
809 DRUG ERUPTION 19 0.0011
810 HEPATIC CIRRHOSIS 20 0.0011
811 HYPOAESTHESIA ORAL 16 0.0011
812 GOUT 19 0.0011
813 ANAPHYLACTIC SHOCK 27 0.0010
814 POST PROCEDURAL COMPLICATION 20 0.0010
815 INTESTINAL OBSTRUCTION 39 0.0010
816 GASTRIC CANCER 26 0.0010
817 LOSS OF CONSCIOUSNESS 131 0.0010
818 HAEMATOCHEZIA 56 0.0010
819 ARRHYTHMIA 48 0.0010
820 PERICARDITIS 17 0.0010
821 OEDEMA PERIPHERAL 123 0.0010
822 ANOREXIA 13 0.0010
823 ISCHAEMIC STROKE 18 0.0010
824 PRODUCT USE ISSUE 188 0.0010
825 BACK PAIN 232 0.0010
826 COGNITIVE DISORDER 46 0.0010
827 DEATH 836 0.0010
828 BLINDNESS 39 0.0010
829 INFLAMMATION 49 0.0009
830 PROTEINURIA 18 0.0009
831 ANGINA PECTORIS 27 0.0009
832 HAEMORRHAGE 98 0.0009
833 PELVIC PAIN 17 0.0009
834 IRRITABILITY 56 0.0009
835 HEAD INJURY 29 0.0009
836 DIABETIC KETOACIDOSIS 22 0.0009
837 DYSPNOEA 513 0.0009
838 DIVERTICULITIS 25 0.0009
839 STEVENS-JOHNSON SYNDROME 20 0.0009
840 OSTEOPOROSIS 37 0.0009
841 WEIGHT DECREASED 249 0.0009
842 CHEST PAIN 163 0.0009
843 FAECES DISCOLOURED 19 0.0009
844 SCAR 15 0.0009
845 TREATMENT FAILURE 72 0.0009
846 SPEECH DISORDER 45 0.0009
847 URINARY TRACT INFECTION 145 0.0008
848 THERAPEUTIC RESPONSE DECREASED 51 0.0008
849 GAIT INABILITY 28 0.0008
850 DYSKINESIA 34 0.0008
851 DRUG INTOLERANCE 80 0.0008
852 MUSCULOSKELETAL PAIN 43 0.0008
853 PARAESTHESIA 129 0.0008
854 LABORATORY TEST ABNORMAL 24 0.0008
855 PNEUMONIA ASPIRATION 20 0.0008
856 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
857 SINUSITIS 82 0.0008
858 INFLUENZA 89 0.0008
859 CHROMATURIA 18 0.0008
860 HEADACHE 499 0.0008
861 LOWER RESPIRATORY TRACT INFECTION 36 0.0008
862 ILL-DEFINED DISORDER 48 0.0008
863 HYPERSENSITIVITY 145 0.0008
864 OESOPHAGEAL CARCINOMA 23 0.0008
865 PAIN IN EXTREMITY 228 0.0008
866 RENAL DISORDER 36 0.0008
867 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
868 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
869 BONE DISORDER 14 0.0008
870 POLLAKIURIA 32 0.0008
871 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
872 FLATULENCE 43 0.0008
873 THERAPY INTERRUPTED 53 0.0007
874 CATARACT 43 0.0007
875 CARDIAC FAILURE CONGESTIVE 58 0.0007
876 FATIGUE 561 0.0007
877 WOUND 20 0.0007
878 HEART RATE DECREASED 25 0.0007
879 HYPOAESTHESIA 105 0.0007
880 GAIT DISTURBANCE 134 0.0007
881 LIP SWELLING 23 0.0007
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
883 SKIN DISORDER 23 0.0007
884 DYSSTASIA 20 0.0007
885 BLOOD GLUCOSE DECREASED 32 0.0007
886 AGGRESSION 33 0.0007
887 ERYTHEMA 133 0.0006
888 VISUAL ACUITY REDUCED 21 0.0006
889 TINNITUS 29 0.0006
890 HYPERHIDROSIS 81 0.0006
891 DRUG INEFFECTIVE 827 0.0006
892 HYPOACUSIS 27 0.0006
893 NECK PAIN 35 0.0006
894 TYPE 2 DIABETES MELLITUS 21 0.0006
895 MYALGIA 106 0.0006
896 SOMNOLENCE 123 0.0006
897 EYE DISORDER 20 0.0006
898 RESTLESSNESS 22 0.0006
899 CHEST DISCOMFORT 60 0.0006
900 SWELLING FACE 38 0.0006
901 ABDOMINAL PAIN UPPER 119 0.0006
902 URINARY INCONTINENCE 17 0.0006
903 TREMOR 95 0.0006
904 MALAISE 250 0.0006
905 PLASMA CELL MYELOMA 22 0.0006
906 BLOOD GLUCOSE INCREASED 105 0.0006
907 VAGINAL HAEMORRHAGE 24 0.0006
908 FALL 179 0.0005
909 BLOOD CHOLESTEROL INCREASED 25 0.0005
910 DIZZINESS 265 0.0005
911 ABASIA 13 0.0005
912 NEPHROLITHIASIS 24 0.0005
913 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
914 BALANCE DISORDER 45 0.0005
915 BLISTER 29 0.0005
916 WHEEZING 30 0.0005
917 DRUG EXPOSURE DURING PREGNANCY 17 0.0005
918 ALOPECIA 98 0.0005
919 MOVEMENT DISORDER 16 0.0005
920 FLUID RETENTION 25 0.0005
921 ARTHRALGIA 204 0.0005
922 BLOOD PRESSURE INCREASED 72 0.0005
923 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
924 ACCIDENTAL OVERDOSE 17 0.0005
925 DIABETES MELLITUS 35 0.0005
926 RHABDOMYOLYSIS 19 0.0005
927 THERAPY CESSATION 23 0.0004
928 DYSPHONIA 26 0.0004
929 ABDOMINAL DISCOMFORT 74 0.0004
930 HIP FRACTURE 14 0.0004
931 EYE SWELLING 16 0.0004
932 PAIN 262 0.0004
933 DISCOMFORT 26 0.0004
934 HALLUCINATION 32 0.0004
935 EXPOSURE DURING PREGNANCY 26 0.0004
936 URTICARIA 70 0.0004
937 AMNESIA 27 0.0004
938 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
939 ANGIOEDEMA 18 0.0004
940 RASH PRURITIC 22 0.0004
941 ABNORMAL BEHAVIOUR 16 0.0004
942 RASH 176 0.0004
943 DEPRESSION 91 0.0004
944 MUSCULOSKELETAL STIFFNESS 35 0.0004
945 SWELLING 37 0.0004
946 CHRONIC KIDNEY DISEASE 30 0.0004
947 MEMORY IMPAIRMENT 54 0.0004
948 MOBILITY DECREASED 28 0.0004
949 NEOPLASM MALIGNANT 26 0.0004
950 MYOCARDIAL INFARCTION 66 0.0004
951 BRONCHITIS 28 0.0004
952 MEDICATION ERROR 21 0.0004
953 SKIN DISCOLOURATION 17 0.0004
954 MIGRAINE 35 0.0004
955 CONTUSION 35 0.0004
956 WEIGHT INCREASED 81 0.0004
957 CEREBROVASCULAR ACCIDENT 61 0.0004
958 PALPITATIONS 42 0.0004
959 FLUSHING 36 0.0004
960 ABORTION SPONTANEOUS 14 0.0003
961 DYSPEPSIA 34 0.0003
962 MENTAL DISORDER 15 0.0003
963 DISTURBANCE IN ATTENTION 18 0.0003
964 TREATMENT NONCOMPLIANCE 18 0.0003
965 UNDERDOSE 24 0.0003
966 VISION BLURRED 44 0.0003
967 OVERDOSE 69 0.0003
968 NASOPHARYNGITIS 54 0.0003
969 NASAL CONGESTION 17 0.0003
970 UNEVALUABLE EVENT 21 0.0003
971 VISUAL IMPAIRMENT 34 0.0003
972 SLEEP DISORDER 19 0.0003
973 INSOMNIA 71 0.0003
974 VERTIGO 16 0.0003
975 PROSTATE CANCER 20 0.0002
976 ILLNESS 25 0.0002
977 ANXIETY 69 0.0002
978 PERIPHERAL SWELLING 37 0.0002
979 MUSCLE SPASMS 37 0.0002
980 DRY MOUTH 16 0.0002
981 INFLUENZA LIKE ILLNESS 16 0.0002
982 PRURITUS 73 0.0002
983 SKIN EXFOLIATION 16 0.0002
984 NO ADVERSE EVENT 30 0.0002
985 SUICIDAL IDEATION 15 0.0002
986 FEELING ABNORMAL 38 0.0002
987 ADVERSE EVENT 13 0.0001
988 HOSPITALISATION 21 0.0001
989 EMOTIONAL DISTRESS 14 0.0001
990 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
991 INCORRECT DOSE ADMINISTERED 15 0.0001